Pfizer explores sale of OTC health brands
October 10, 2017
Pfizer, which manufactures brands including Advil, Centrum, ChapStick and Robitussin, is considering whether to sell its portfolio of over-the-counter (OTC) remedies to focus on its prescription medicine business. Pfizer’s consumer brands business generated $3.4 billion in sales last year. The company’s prescription medicines, which include Lipitor and Viagra, generated a profit of $3.07 billion in the second quarter on sales of $12.9 billion.
Recent News
Tech Experts Claim Multimodal AI Is the Next Big Thing
In the ever-evolving landscape of technology, there’s a new contender stealing the spotlight: multimodal AI.
McDonald’s May Be Ending Its Free Drink Refills
The days of patrons refilling their own cups will be over by 2032.
Trump Embraces Cryptocurrency to Mixed Responses
Former President Donald Trump’s recent embrace of the cryptocurrency market has stirred both excitement and skepticism within the industry.
Bumble Is Sorry for Ads That Mock Celibacy
The dating app is in hot water for its newest ad campaign.